Health care researchers are calling for more proactive oversight of online direct-to-consumer (DTC) platforms that prescribe weight loss drugs, as well as more clarity on which agency is responsible for regulating the sellers. This comes amid an ongoing debate between FDA and Congress regarding the regulation of telehealth DTC advertisements. Researchers who published a commentary in the New England Journal of Medicine recommended establishing a national certification program that would provide a standardized framework for direct-to-consumer platforms in prescribing...